Department of Chemistry, Aarhus University, Langelandsgade 140, 8000 Aarhus C, Denmark.
Department of Biochemistry, University of Oxford, South Parks Road, Oxford OX1 3QU, U.K.
ACS Chem Neurosci. 2022 Apr 20;13(8):1129-1142. doi: 10.1021/acschemneuro.1c00029. Epub 2022 Mar 29.
G-protein coupled receptors (GPCRs) are important pharmacological targets. Despite substantial progress, important questions still remain concerning the details of activation: how can a ligand act as an agonist in one receptor but as an antagonist in a homologous receptor, and how can agonists activate a receptor despite lacking polar functional groups able to interact with helix 5 as is the case for the related adrenergic receptors? Studying vortioxetine (VXT), an important multimodal antidepressant drug, may elucidate both questions. Herein, we present a thorough in silico analysis of VXT binding to 5-HT, 5-HT, and 5-HT receptors and compare it with available experimental data. We are able to rationalize the differential mode of action of VXT at different receptors, but also, in the case of the 5-HT receptor, we observe the initial steps of activation that inform about an activation mechanism that does not involve polar interaction with helix 5. The results extend our current understanding of agonist and antagonist action at aminergic GPCRs.
G 蛋白偶联受体(GPCRs)是重要的药理学靶点。尽管已经取得了很大的进展,但关于激活的细节仍存在一些重要问题:为什么一种配体在一种受体中作为激动剂起作用,而在同源受体中作为拮抗剂起作用,为什么激动剂能够激活受体,尽管它们缺乏能够与螺旋 5 相互作用的极性官能团,就像相关的肾上腺素能受体一样?研究文拉法辛(VXT),一种重要的多模式抗抑郁药,可能会阐明这两个问题。在此,我们对文拉法辛与 5-HT、5-HT 和 5-HT 受体的结合进行了全面的计算分析,并将其与现有实验数据进行了比较。我们能够合理地解释文拉法辛在不同受体上的不同作用模式,但在 5-HT 受体的情况下,我们观察到了激活的初始步骤,这些步骤提供了一种不涉及与螺旋 5 极性相互作用的激活机制。这些结果扩展了我们对单胺能 GPCR 激动剂和拮抗剂作用的现有认识。